JPWO2018217809A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2018217809A5 JPWO2018217809A5 JP2019565399A JP2019565399A JPWO2018217809A5 JP WO2018217809 A5 JPWO2018217809 A5 JP WO2018217809A5 JP 2019565399 A JP2019565399 A JP 2019565399A JP 2019565399 A JP2019565399 A JP 2019565399A JP WO2018217809 A5 JPWO2018217809 A5 JP WO2018217809A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- solvate
- pharmaceutically acceptable
- hydrate
- tautomer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762510223P | 2017-05-23 | 2017-05-23 | |
| US62/510,223 | 2017-05-23 | ||
| PCT/US2018/033964 WO2018217809A1 (en) | 2017-05-23 | 2018-05-22 | Pyrazole magl inhibitors |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2020521767A JP2020521767A (ja) | 2020-07-27 |
| JP2020521767A5 JP2020521767A5 (enrdf_load_stackoverflow) | 2021-07-26 |
| JPWO2018217809A5 true JPWO2018217809A5 (enrdf_load_stackoverflow) | 2022-07-26 |
| JP7162622B2 JP7162622B2 (ja) | 2022-10-28 |
Family
ID=64397012
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019565399A Active JP7162622B2 (ja) | 2017-05-23 | 2018-05-22 | ピラゾールｍａｇｌ阻害剤 |
Country Status (23)
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2015508407A (ja) | 2012-01-06 | 2015-03-19 | アビデ セラピューティクス，インク． | カルバメート化合物およびその製造および使用 |
| US10583137B2 (en) | 2015-12-02 | 2020-03-10 | The Scripps Research Institute | Triazole DAGLα inhibitors |
| JOP20190107A1 (ar) | 2016-11-16 | 2019-05-09 | Lundbeck La Jolla Research Center Inc | مثبطات أحادي أسيل جليسرول ليباز (magl) |
| JOP20190105A1 (ar) * | 2016-11-16 | 2019-05-09 | Lundbeck La Jolla Research Center Inc | مثبطات أحادي أسيل جليسرول ليباز (magl) |
| CN110678456B (zh) | 2017-05-23 | 2023-05-02 | H.隆德贝克有限公司 | 吡唑magl抑制剂 |
| US10927105B1 (en) | 2017-05-23 | 2021-02-23 | Lundbeck La Jolla Research Center, Inc. | Pyrazole MAGL inhibitors |
| JOP20190267A1 (ar) | 2017-05-23 | 2019-11-18 | Lundbeck La Jolla Research Center Inc | مثبطات بيرازول magl |
| TW201938164A (zh) | 2018-01-08 | 2019-10-01 | 瑞士商赫孚孟拉羅股份公司 | 新穎雜環化合物 |
| AU2020311584A1 (en) * | 2019-07-09 | 2022-01-20 | F. Hoffmann-La Roche Ag | New heterocyclic compounds |
| WO2022057928A1 (zh) * | 2020-09-18 | 2022-03-24 | 上海医药集团股份有限公司 | 一种羰基杂环类化合物及其应用 |
| EP4284365A4 (en) | 2021-01-29 | 2024-12-18 | Cedilla Therapeutics, Inc. | CDK2 INHIBITORS AND METHODS OF USE THEREOF |
| CN117561058A (zh) | 2021-06-26 | 2024-02-13 | 塞迪拉治疗股份有限公司 | Cdk2抑制剂及其使用方法 |
| IL313987A (en) | 2021-12-29 | 2024-08-01 | Psy Therapeutics Inc | Inhibiting monoacylglycerol lipase (magl) |
| WO2024168426A1 (en) | 2023-02-13 | 2024-08-22 | Apogee Pharmaceuticals, Inc. | Small molecules as monoacylglycerol lipase (magl) inhibitors, compositions and use thereof |
| WO2025221154A1 (en) | 2024-04-17 | 2025-10-23 | Captor Therapeutics S.A. | Klhdc2 (kelch domain-containing protein 2) ligase ligands |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3308130A (en) | 1962-04-26 | 1967-03-07 | Du Pont | N-disubstituted carbamyl pyrazoles |
| MXPA03001421A (es) | 2000-08-14 | 2004-01-26 | Johnson & Johnson | Pirazoles sustituidos. |
| US6727364B2 (en) | 2001-04-30 | 2004-04-27 | The Procter & Gamble Company | Triazole compounds useful in treating diseases associated with unwanted cytokine activity |
| US7122681B2 (en) * | 2002-02-19 | 2006-10-17 | Teva Pharmaceutical Industries, Ltd. | Desolvation process for the production of atorvastatin hemi-calcium essentially free of bound organic solvent |
| SE0300705D0 (sv) | 2003-03-14 | 2003-03-14 | Biolipox Ab | New compounds |
| WO2008023720A1 (en) | 2006-08-23 | 2008-02-28 | Astellas Pharma Inc. | Urea compound or salt thereof |
| RU2553451C2 (ru) | 2008-12-24 | 2015-06-20 | Биал-Портела Энд Ка, С.А. | Фармацевтические соединения |
| WO2012138877A1 (en) | 2011-04-06 | 2012-10-11 | The Scripps Research Institute | N1- and n2-carbamoyl-1,2,3-triazole serine hydrolase inhibitors and methods |
| CN103130723B (zh) | 2011-11-30 | 2015-01-14 | 成都地奥制药集团有限公司 | 一种多聚(adp-核糖)聚合酶抑制剂 |
| WO2015099196A1 (en) | 2013-12-26 | 2015-07-02 | Takeda Pharmaceutical Company Limited | 4-(piperrazin-1-yl)-pyrrolidin-2-one compounds as monoacylglycerol lipase (magl) inhibitors |
| US10093630B2 (en) | 2014-05-21 | 2018-10-09 | Abide Therapeutics, Inc. | Pyrazole compounds and methods of making and using same |
| BR112017001353B1 (pt) * | 2014-07-23 | 2022-02-22 | Baker Hughes Incorporated | Aparelho e método para monitorar escala orgânica de fundo de poço e intervir em um poço de produção |
| WO2016014975A2 (en) | 2014-07-25 | 2016-01-28 | Northeastern University | Urea/carbamates faah magl or dual faah/magl inhibitors and uses thereof |
| BR112018000041A2 (pt) | 2015-07-31 | 2018-09-04 | Pfizer Inc. | Derivados de carbamato de 1,1,1-trifluoro-3- hidroxipropan-2-ila e derivados de carbamato de 1,1,1-trifluoro-4-hidroxibutan-2-ila como inibidores de magl |
| US10519134B2 (en) | 2015-11-20 | 2019-12-31 | Lundbeck La Jolla Research Center, Inc. | Pyrazole compounds and methods of making and using same |
| WO2017087858A1 (en) | 2015-11-20 | 2017-05-26 | Abide Therapeutics, Inc. | Pyrazole compounds and methods of making and using same |
| WO2017087863A1 (en) | 2015-11-20 | 2017-05-26 | Abide Therapeutics, Inc. | Pyrazole compounds and methods of making and using same |
| US10583137B2 (en) | 2015-12-02 | 2020-03-10 | The Scripps Research Institute | Triazole DAGLα inhibitors |
| US10927105B1 (en) | 2017-05-23 | 2021-02-23 | Lundbeck La Jolla Research Center, Inc. | Pyrazole MAGL inhibitors |
| JOP20190267A1 (ar) | 2017-05-23 | 2019-11-18 | Lundbeck La Jolla Research Center Inc | مثبطات بيرازول magl |
| CN110678456B (zh) | 2017-05-23 | 2023-05-02 | H.隆德贝克有限公司 | 吡唑magl抑制剂 |
-
2017
- 2017-06-16 JO JOP/2019/0267A patent/JOP20190267A1/ar unknown
-
2018
- 2018-05-22 MA MA050405A patent/MA50405A/fr unknown
- 2018-05-22 KR KR1020197037406A patent/KR20200010366A/ko not_active Withdrawn
- 2018-05-22 MX MX2019014041A patent/MX2019014041A/es unknown
- 2018-05-22 EA EA201992504A patent/EA201992504A1/ru unknown
- 2018-05-22 CR CR20190537A patent/CR20190537A/es unknown
- 2018-05-22 WO PCT/US2018/033964 patent/WO2018217809A1/en not_active Ceased
- 2018-05-22 CN CN201880033866.9A patent/CN110678177B/zh active Active
- 2018-05-22 JP JP2019565399A patent/JP7162622B2/ja active Active
- 2018-05-22 AU AU2018273888A patent/AU2018273888A1/en not_active Abandoned
- 2018-05-22 PE PE2019002453A patent/PE20200293A1/es unknown
- 2018-05-22 ES ES18805515T patent/ES3005265T3/es active Active
- 2018-05-22 BR BR112019024488-3A patent/BR112019024488A2/pt not_active Application Discontinuation
- 2018-05-22 EP EP18805515.6A patent/EP3634404B1/en active Active
- 2018-05-22 CA CA3065898A patent/CA3065898A1/en not_active Abandoned
- 2018-05-22 RU RU2019137094A patent/RU2019137094A/ru not_active Application Discontinuation
- 2018-05-22 US US16/615,746 patent/US11149037B2/en active Active
-
2019
- 2019-11-20 DO DO2019000295A patent/DOP2019000295A/es unknown
- 2019-11-21 CO CONC2019/0013016A patent/CO2019013016A2/es unknown
- 2019-11-21 CL CL2019003398A patent/CL2019003398A1/es unknown
- 2019-11-22 PH PH12019502646A patent/PH12019502646A1/en unknown
- 2019-11-22 NI NI201900120A patent/NI201900120A/es unknown
- 2019-11-25 EC ECSENADI201983923A patent/ECSP19083923A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020521767A5 (enrdf_load_stackoverflow) | ||
| JPWO2018217809A5 (enrdf_load_stackoverflow) | ||
| RU2019137094A (ru) | Ингибиторы magl на основе пиразола | |
| JP3298641B2 (ja) | イミダゾール誘導体およびそのサイトカイン阻害剤としての使用 | |
| ES2609987T3 (es) | Piridinonas bicíclicas novedosas | |
| CN115427414A (zh) | 稠环化合物及其在医药上的应用 | |
| CN113614080A (zh) | Kras g12c抑制剂化合物及其用途 | |
| JP2019077725A5 (enrdf_load_stackoverflow) | ||
| CA3180819A1 (en) | Substituted aminothiazoles as dgkzeta inhibitors for immune activation | |
| JP2019527731A (ja) | Ｈｂｖ感染の治療のための新規治療薬 | |
| CN103874492B (zh) | 不对称脲及其医学应用 | |
| RU2013123275A (ru) | Пиперидин-4-илазетидиндиамиды как ингибиторы моноацилглицеринлипазы | |
| CN115175905A (zh) | Zeste增强子同源物2抑制剂及其用途 | |
| EA018995B1 (ru) | Производные карбаматов алкилтиазолов, их получение и их применение в терапии | |
| JP2020521766A5 (enrdf_load_stackoverflow) | ||
| AU2008331456A1 (en) | Renin inhibitors | |
| JP2013542267A5 (enrdf_load_stackoverflow) | ||
| CA3178372A1 (en) | Enpp1 modulators and uses thereof | |
| JP5892550B2 (ja) | 縮合イミダゾール誘導体 | |
| JP2004525183A5 (enrdf_load_stackoverflow) | ||
| RU2007116987A (ru) | Новые соединения | |
| US9695198B2 (en) | Factor IXa inhibitors | |
| JP2020503292A5 (enrdf_load_stackoverflow) | ||
| JP2019522048A5 (enrdf_load_stackoverflow) | ||
| RU2009139073A (ru) | Соединения хинолина для лечения нарушений, которые реагируют на модуляцию рецептора серотонина 5-нт6 |